SCHEMBL12607194

SCHEMBL12607194

CON(C)S(=O)(=O)CC1(NC(=O)N[C@H]2CCCCCCCCC[C@@H](C(=O)C(=O)NC3CC3)NC(=O)[C@@H]3[C@@H]4[C@H](CN3C2=O)C4(C)C)CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12607977 0.94 — —
SCHEMBL12608059 0.94 — —
SCHEMBL12606747 0.94 — —
SCHEMBL12607506 0.92 — —
SCHEMBL8045471 0.92 — —
SCHEMBL12608088 0.88 — —
SCHEMBL12606754 0.88 — —
SCHEMBL8048698 0.88 — —
SCHEMBL12606718 0.88 — —
SCHEMBL13684783 0.88 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110150835-A1 Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease SCHERING CORPORATION 2011-06-23 — — US disclosed
Send feedback